We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Neil Korman, MD, PhD
Accepting New Patients

Neil Korman, MD, PhD

Schedule an Appointment:

Or call 216-844-8200

Office Locations

DO Bolwell 3100 (0 mi.)

11100 Euclid Ave
Suite: 3100
Cleveland, OH 44106
216-844-8200

UHMG Dermatology (5 mi.)

3000 Auburn Dr
Suite: 125
Beachwood, OH 44122
216-844-8200

DO 950 Clague (15 mi.)

950 Clague Rd
Suite: 104
Westlake, OH 44145
216-844-8200

DO 2820 W Market (26 mi.)

2820 W Market St
Suite: 210
Fairlawn, OH 44333
216-844-8200

Biography: Neil Korman, MD, PhD

Expertise

  • Atopic Dermatitis (Eczema)
  • Blistering Diseases
  • Clinical Trials Research
  • Dermatology
  • Immunotherapy
  • Psoriasis

Titles

  • Director, Clinical Trials Unit, UH Cleveland Medical Center
  • Director, Murdough Family Center for Psoriasis, UH Cleveland Medical Center
  • Professor, CWRU School of Medicine

Certifications & Memberships

  • Clinical and Laboratory Dermatological Immunology - American Board of Dermatology
  • Dermatology - American Board of Dermatology

Education

Fellowship | Dermatology
Dermatology - Clinical Center At The National Institutes Of Health (1987 - 1990)

Residency | Dermatology
Dermatology - University Hospitals Of Cleveland (1985 - 1987)

Internship | Internal Medicine
Internal Medicine - University Hospitals Of Cleveland (1984 - 1985)

Medical Education
Case Western Reserve University School Of Medicine (1984)

Other Education
Case Western Reserve University (1982)

Other Education
Suny Stony Brook University (1977)

Undergraduate
Suny Stony Brook University (1976)

Research & Publications

Research Links

PubMed
View Research

Research Interests

Psoriasis research, Bullous disease research, Translational research

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Brenda McGhee did not disclose any Outside Relationships with Industry.